Three publications since the last update:

• Clinical and economic impact of genome-wide non-invasive prenatal testing (NIPT) as a first-tier screening method compared to targeted NIPT and first-trimester combined testing: A modeling study | link
• Patient and population impacts of multi-gene panel and pembrolizumab coverage in metastatic melanoma | link
• The cost and cost trajectory of genome sequencing and bioinformatics analysis for Indigenous children with suspected rare diseases | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.